BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lampropoulou DI, Pliakou E, Aravantinos G, Filippou D, Gazouli M. The Role of Exosomal Non-Coding RNAs in Colorectal Cancer Drug Resistance. Int J Mol Sci 2022;23:1473. [PMID: 35163397 DOI: 10.3390/ijms23031473] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Chavda VP, Pandya A, Kumar L, Raval N, Vora LK, Pulakkat S, Patravale V, Salwa, Duo Y, Tang BZ. Exosome nanovesicles: A potential carrier for therapeutic delivery. Nano Today 2023;49:101771. [DOI: 10.1016/j.nantod.2023.101771] [Reference Citation Analysis]
2 Masoudi-Khoram N, Soheilifar MH, Ghorbanifar S, Nobari S, Hakimi M, Hassani M. Exosomes derived from cancer-associated fibroblasts mediate response to cancer therapy. Crit Rev Oncol Hematol 2023;:103967. [PMID: 36965647 DOI: 10.1016/j.critrevonc.2023.103967] [Reference Citation Analysis]
3 Tan S, Yang Y, Yang W, Han Y, Huang L, Yang R, Hu Z, Tao Y, Liu L, Li Y, Oyang L, Lin J, Peng Q, Jiang X, Xu X, Xia L, Peng M, Wu N, Tang Y, Cao D, Liao Q, Zhou Y. Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment. J Exp Clin Cancer Res 2023;42:59. [PMID: 36899389 DOI: 10.1186/s13046-023-02634-z] [Reference Citation Analysis]
4 Chen L, Chen X, Niu X, Peng X. LncRNAs in colorectal cancer: Biomarkers to therapeutic targets. Clinica Chimica Acta 2023;543:117305. [DOI: 10.1016/j.cca.2023.117305] [Reference Citation Analysis]
5 Wang N, Ma T, Yu B. Targeting epigenetic regulators to overcome drug resistance in cancers. Signal Transduct Target Ther 2023;8:69. [PMID: 36797239 DOI: 10.1038/s41392-023-01341-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Xu P, Cheng S, Wang X, Jiang S, He X, Tang L, Wu N, Yang Z. The hsa_circ_0039857/miR-338-3p/RAB32 axis promotes the malignant progression of colorectal cancer. BMC Gastroenterol 2022;22:530. [PMID: 36539702 DOI: 10.1186/s12876-022-02622-1] [Reference Citation Analysis]
7 Zare M, Pemmada R, Madhavan M, Shailaja A, Ramakrishna S, Kandiyil SP, Donahue JM, Thomas V. Encapsulation of miRNA and siRNA into Nanomaterials for Cancer Therapeutics. Pharmaceutics 2022;14. [PMID: 36015246 DOI: 10.3390/pharmaceutics14081620] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Yao X, Zhang Q. Function and Clinical Significance of Circular RNAs in Thyroid Cancer. Front Mol Biosci 2022;9:925389. [DOI: 10.3389/fmolb.2022.925389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Oryani MA, Tavasoli A, Ghalavand MA, Ashtiani RZ, Rezaee A, Mahmoudi R, Golvari H, Owrangi S, Soleymani-Goloujeh M. Epigenetics and its therapeutic potential in colorectal cancer. Epigenomics 2022. [PMID: 35473313 DOI: 10.2217/epi-2022-0067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]